PD-011SAPPHIRE: A randomized phase II study of oxaliplatin discontinuation after 6 cycles of mFOLFOX6 + panitumumab therapy in patients with colorectal cancer: Final analysis of efficacy and safety results. (20th June 2018) - Takahashi, M; Munemoto, Y; Nakamura, M; Kotaka, M; Kuroda, H; Kato, T; Minagawa, N; Noura, S; Fukunaga, M; Kuramochi, H; Touyama, T; Takahashi, T; et al.